EIKON THERAPEUTICS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at EIKON THERAPEUTICS is $140,795, based on 39 certified filings from FY 2021 to FY 2026. This is 17% higher than the national H-1B median salary of $120,000. Compensation at EIKON THERAPEUTICS reflects their market positioning, with entry-level roles starting around $123,559 and senior positions reaching $181,272 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at EIKON THERAPEUTICS range from $89,024 at the 10th percentile to $181,272 at the 90th percentile, showing a $92,248 spread across experience levels and roles. The 25th percentile is $123,559 and the 75th percentile is $170,373.

Yes, EIKON THERAPEUTICS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 41 H-1B labor condition applications from FY 2021 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 39 certified applications and a 0% denial rate, EIKON THERAPEUTICS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), EIKON THERAPEUTICS filed 1 H-1B applications, with 1 certified and 0 denied. Over 6 years of data, EIKON THERAPEUTICS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

EIKON THERAPEUTICS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 41 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating EIKON THERAPEUTICS as a potential H-1B sponsor.

This is an excellent approval rate, indicating EIKON THERAPEUTICS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

EIKON THERAPEUTICS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 39 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles EIKON THERAPEUTICS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at EIKON THERAPEUTICS:

The most frequently sponsored role is Software Engineer with 3 filings at a median salary of $130,250. This is followed by Senior Software Engineer (2 filings) and Senior Informatics Engineer.

EIKON THERAPEUTICS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where EIKON THERAPEUTICS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top EIKON THERAPEUTICS H-1B locations:

The largest H-1B hub for EIKON THERAPEUTICS is Hayward, CA with 23 filings at a median salary of $140,000. The highest-paying location is Portland, OR at $182,790 median. Salaries range from $104,957 to $182,790 across office locations.

EIKON THERAPEUTICS's median H-1B salary has changed by -7% from FY 2021 ($140,000) to FY 2026 ($129,667). Tracking salary trends over time reveals how EIKON THERAPEUTICS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at EIKON THERAPEUTICS.

Year-by-year breakdown:

• FY 2022: $155,800 (3 certified)
• FY 2023: $149,989 (6 certified)
• FY 2024: $138,362 (18 certified)
• FY 2025: $170,373 (10 certified)
• FY 2026: $129,667 (1 certified)

Salary levels have remained relatively stable at EIKON THERAPEUTICS.

EIKON THERAPEUTICS primarily files H-1B applications at Wage Level IV, accounting for 31% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making EIKON THERAPEUTICS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

EIKON THERAPEUTICS has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

EIKON THERAPEUTICS's median H-1B salary of $140,795 is 17% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating EIKON THERAPEUTICS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare EIKON THERAPEUTICS's offerings with similar companies in your field for a more accurate assessment.

EIKON THERAPEUTICS offers above-average H-1B compensation. Combined with their 39 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. EIKON THERAPEUTICS's higher proportion of Level III-IV positions (51%) may benefit from wage-based lottery prioritization.

With 39 certified filings, EIKON THERAPEUTICS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.